Corcept Therapeutics (CORT) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $79.71 --0%
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $81.5 million versus the consensus estimate of $78 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Ennis (EBF) Reports In-Line Q1 EPS
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
